Orchid Pharma Limited (NSE:ORCHPHARMA)

India · Delayed Price · Currency is INR

495.50

-13.05 (-2.57%)

Mar 9, 2026, 2:34 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	9.22B	8.19B	6.66B	5.60B	4.50B
Pharmaceuticals Growth	12.52%	23.05%	19.00%	24.33%	-6.97%
Total	9.22B	8.19B	6.66B	5.60B	4.50B
Total Growth	12.52%	23.05%	19.00%	24.33%	-6.97%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	1.81B	1.49B	1.04B	766.14M	538.06M
India Growth	21.13%	43.77%	35.60%	42.39%	27.69%
Rest of the World	7.28B	6.66B	5.52B	4.79B	3.84B
Rest of the World Growth	9.38%	20.67%	15.07%	24.74%	-9.16%
Total	9.09B	8.15B	6.56B	5.56B	4.38B
Total Growth	11.53%	24.33%	17.90%	26.90%	-5.82%

Source: S&P Global Market Intelligence.